אבוסינאגיס 50 מ"ג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

PALIVIZUMAB 50 MG

Dostupno od:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

ATC koda:

J06BB16

Farmaceutski oblik:

POWDER FOR SOLUTION FOR INJECTION

Administracija rute:

I.M

Proizveden od:

ABBVIE S.R.L., ITALY

Terapijska grupa:

PALIVIZUMAB

Terapijske indikacije:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Datum autorizacije:

2010-07-01